Cannara Biotech (OTC:CNBTF) will expand its cannabis cultivation and process capacity by 40K sq. ft. to 170K sq. ft. as part of its Phase 1 build-out plan. It has modified its license application with Health Canada accordingly.
The company says it is building one of the largest indoor cannabis cultivation facilities (625K sq. ft.) in Canada and the largest in Quebec.
Subscribe for full text news in your inbox